These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 33916521)
1. Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention. Vietri MT; D'Elia G; Caliendo G; Resse M; Casamassimi A; Passariello L; Albanese L; Cioffi M; Molinari AM Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916521 [TBL] [Abstract][Full Text] [Related]
2. Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in D'Elia G; Caliendo G; Tzioni MM; Albanese L; Passariello L; Molinari AM; Vietri MT Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292577 [TBL] [Abstract][Full Text] [Related]
3. Genetic testing for hereditary prostate cancer: Current status and limitations. Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169 [TBL] [Abstract][Full Text] [Related]
4. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer. Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772 [TBL] [Abstract][Full Text] [Related]
5. Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications. Brandão A; Paulo P; Teixeira MR Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708810 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men. Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035 [TBL] [Abstract][Full Text] [Related]
7. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. Wokołorczyk D; Kluźniak W; Huzarski T; Gronwald J; Szymiczek A; Rusak B; Stempa K; Gliniewicz K; Kashyap A; Morawska S; Dębniak T; Jakubowska A; Szwiec M; Domagała P; Lubiński J; Narod SA; Akbari MR; Cybulski C; Int J Cancer; 2020 Nov; 147(10):2793-2800. PubMed ID: 32875559 [TBL] [Abstract][Full Text] [Related]
8. Bringing Prostate Cancer Germline Genetics into Clinical Practice. Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411 [TBL] [Abstract][Full Text] [Related]
9. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine. Marino F; Totaro A; Gandi C; Bientinesi R; Moretto S; Gavi F; Pierconti F; Iacovelli R; Bassi P; Sacco E Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):655-664. PubMed ID: 36434163 [TBL] [Abstract][Full Text] [Related]
10. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort. Wei J; Yang W; Shi Z; Lu L; Wang Q; Resurreccion WK; Engelmann V; Zheng SL; Hulick PJ; Cooney KA; Isaacs WB; Helfand BT; Lu J; Xu J Prostate; 2021 Sep; 81(13):1002-1008. PubMed ID: 34254341 [TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Germline Variations and Implications for Screening and Treatment. Dias A; Kote-Jarai Z; Mikropoulos C; Eeles R Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29101112 [TBL] [Abstract][Full Text] [Related]
12. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
13. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1). Sorscher S; Ansley K; Delaney SD; Ramkissoon S Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686 [TBL] [Abstract][Full Text] [Related]
14. Germline and Somatic Mutations in Prostate Cancer for the Clinician. Cheng HH; Sokolova AO; Schaeffer EM; Small EJ; Higano CS J Natl Compr Canc Netw; 2019 May; 17(5):515-521. PubMed ID: 31085765 [TBL] [Abstract][Full Text] [Related]
15. A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome. Rashid MU; Naeemi H; Muhammad N; Loya A; Yusuf MA; Lubiński J; Jakubowska A; Hamann U Hered Cancer Clin Pract; 2016; 14():14. PubMed ID: 27413415 [TBL] [Abstract][Full Text] [Related]
16. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129 [TBL] [Abstract][Full Text] [Related]
17. Germline genetic variants in men with prostate cancer and one or more additional cancers. Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667 [TBL] [Abstract][Full Text] [Related]
18. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing. Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082 [TBL] [Abstract][Full Text] [Related]